These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 7543485)

  • 1. An approach to antiretroviral treatment of HIV disease. New approaches.
    Pollard RB; Onorato M
    Hosp Pract (1995); 1995 Aug; 30 Suppl 1():32-40. PubMed ID: 7543485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is there a role for non-nucleoside reverse transcriptase inhibitors in the treatment of HIV infection?
    Kilby JM; Saag MS
    Infect Agents Dis; 1994 Dec; 3(6):313-23. PubMed ID: 7534192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
    Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rationale and experience with reverse transcriptase inhibitors and protease inhibitors.
    Vella S
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S58-61. PubMed ID: 8595511
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel concepts in the treatment of human immunodeficiency virus type 1 (HIV-1) infections by HIV-1-specific reverse transcriptase inhibitors.
    Balzarini J
    Verh K Acad Geneeskd Belg; 1995; 57(6):575-600. PubMed ID: 8686372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Update on antiretroviral therapy.
    Hicks CB
    Radiol Clin North Am; 1997 Sep; 35(5):995-1005. PubMed ID: 9298086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapeutic approaches to human immunodeficiency virus infections.
    Baba M
    Fukushima J Med Sci; 1992 Jun; 38(1):1-18. PubMed ID: 1284048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Virological evaluation of treating HIV-infected patients with (combinations of) antiretroviral drugs at the Amsterdam Academic Medical Center, 1996/'97].
    de Wolf F; de Jong JJ; Hertogs K; Danner SA; Lange JM; Goudsmit J
    Ned Tijdschr Geneeskd; 1998 Mar; 142(11):573-8. PubMed ID: 9623114
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV-1 reverse transcriptase inhibitors.
    El Safadi Y; Vivet-Boudou V; Marquet R
    Appl Microbiol Biotechnol; 2007 Jun; 75(4):723-37. PubMed ID: 17370068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiretroviral drug treatment for HIV/AIDS.
    Goldschmidt RH; Moy A
    Am Fam Physician; 1996 Aug; 54(2):574-80, 587-8. PubMed ID: 8701838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antiviral therapy of HIV infection. A practice-based presentation 1997/1998].
    Becker W
    Fortschr Med; 1997 Nov; 115(32):30-4. PubMed ID: 9480261
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A short-term clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. L-697,661 Working Group.
    Saag MS; Emini EA; Laskin OL; Douglas J; Lapidus WI; Schleif WA; Whitley RJ; Hildebrand C; Byrnes VW; Kappes JC
    N Engl J Med; 1993 Oct; 329(15):1065-72. PubMed ID: 7690462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current approaches to treatment for HIV-1 infection.
    Powderly WG
    J Neurovirol; 2000 May; 6 Suppl 1():S8-S13. PubMed ID: 10871760
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment strategies and surveillance of chronic HIV infection in adults].
    Joly V; Yeni P
    Rev Prat; 1999 Oct; 49(16):1773-80. PubMed ID: 10578608
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV/AIDS management in office practice. Antiretroviral therapy.
    Hartman AF
    Prim Care; 1997 Sep; 24(3):531-60. PubMed ID: 9271691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recent development of novel reverse transcriptase inhibitors and protease inhibitors against HIV-1 infection].
    Koh Y
    Nihon Rinsho; 2010 Mar; 68(3):512-9. PubMed ID: 20229800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel HIV-1 reverse transcriptase inhibitors.
    Jochmans D
    Virus Res; 2008 Jun; 134(1-2):171-85. PubMed ID: 18308412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polymorphism in HIV-1 non-subtype B protease and reverse transcriptase and its potential impact on drug susceptibility and drug resistance evolution.
    Kantor R; Katzenstein D
    AIDS Rev; 2003; 5(1):25-35. PubMed ID: 12875105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationships among various nucleoside resistance-conferring mutations in the reverse transcriptase of HIV-1.
    Turner D; Brenner B; Wainberg MA
    J Antimicrob Chemother; 2004 Jan; 53(1):53-7. PubMed ID: 14645322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antiretroviral resistance mutations in human immunodeficiency virus type 1 reverse transcriptase and protease from paired cerebrospinal fluid and plasma samples.
    Venturi G; Catucci M; Romano L; Corsi P; Leoncini F; Valensin PE; Zazzi M
    J Infect Dis; 2000 Feb; 181(2):740-5. PubMed ID: 10669367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.